Cerebrospinal fluid biomarkers and cognitive status in differential diagnosis of frontotemporal dementia and Alzheimer’s disease

OBJECTIVE: This study aimed to determine the most appropriate cognitive and cerebrospinal fluid (CSF) biomarker setting to distinguish frontotemporal dementia (FTD) from Alzheimer’s disease (AD). METHOD: Patients with FTD, those with AD, and those without dementia were enrolled in this study. CSF am...

Descripción completa

Detalles Bibliográficos
Autores principales: Casoli, Tiziana, Paolini, Susy, Fabbietti, Paolo, Fattoretti, Patrizia, Paciaroni, Lucia, Fabi, Katia, Gobbi, Beatrice, Galeazzi, Roberta, Rossi, Roberto, Lattanzio, Fabrizia, Pelliccioni, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Clinical Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833432/
https://www.ncbi.nlm.nih.gov/pubmed/31524025
http://dx.doi.org/10.1177/0300060519860951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833432/
https://www.ncbi.nlm.nih.gov/pubmed/31524025
http://dx.doi.org/10.1177/0300060519860951

Ejemplares similares